ACTA NEUROPHARMACOLOGICA››2014,Vol. 4››Issue (5): 15-23.
Previous ArticlesNext Articles
WANG Qian TIAN Hui LIU Liang-jing ZHONG Ming MEI Yan-fei ZHANG Li
Online:
2014-10-26Published:
2015-01-20Contact:
张力,男,教授,硕士生导师;研究方向:神经药理学;E-mail:zmczl@hotmail.comAbout author:
王倩,女,硕士;研究方向:神经药理学;E-mail:wangqianpharmacy@126.comSupported by:
国家自然基金课题(No. 81274005)
CLC Number:
WANG Qian TIAN Hui LIU Liang-jing ZHONG Ming MEI Yan-fei ZHANG Li.Establishment of model about Ulcerative Colitis and the Mechanism of Colitis-related Inflammatory Responses[J]. ACTA NEUROPHARMACOLOGICA, 2014, 4(5): 15-23.
1. Tom C DeRoche, Xiao Shu-Yuan , Liu Xiu-li . Histological evaluation in ulcerative colitis[J]. Gastroenterol Rep (Oxf), 2014, 2(3): 178–192. 2. Kotaro Tozawa, Hiroyuki Hanai, Ken Sugimoto, et al. Evidence for the critical role of interleukin‐12 but not interferon‐γ in the pathogenesis of experimental colitis in mice[J]. J Gastroenterol Hepatol, 2003, 18(5): 578-587. 3. Morris G P, Beck P L, Herridge M S, et al. Hapten-induced model of chronic inflammation and ulceration in the rat colon[J]. Gastroenterology, 1989, 96(3):795–803. 4. Walter E Cromer, Chaitanya V Ganta, Mihir Patel, et al. VEGF-A isoform modulation in an preclinical TNBS model of ulcerative colitis: protective effects of a VEGF164b therapy[J] .J Transl Med, 2013, 11(11):207. 5. Heller F, Fuss I J, Nieuwenhuis E E, et al. Oxazolone colitis, aTh2colitismodel resembling ulcerative colitis, ismediated byIL-13-producing NK-T cells [J] .Immunity, 2002,17(5): 629-638. 6. Okayasu I, Hatakeyama S, Yamada M, et al. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice [J] .Gastroenterology, 1990, 98(3): 694-702. 7. S N S Murfliy, Harry S Cooper, Helen Shim, et al. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin [J]. Dig Dis Sci, 1993, 38(9):1722-1734. 8. Ho H Luk, Joshua K Ko, Hon S Fung, et al. Delineation the protective action of zinc sulfate on ulcerative colitis in rats[J]. Eur Pharmaco, 2002, 443(1-3):197-204. 9. Ekstrom G M. Oxazolone-induced colitis in rats: effects of budesonide, cyclosporinE, and 5-aminosalicylic acid[J]. Scand J Gastroenterol, 1998, 33(2):174-179. 10. Sung-Chui Lim, Tae-Beum Lee, Cheol-Hee Choi, et al. Expression of cyclooxygenase-2 and its relationship to p53 accumulation in colorectal cancers[J]. Yonsei medical J, 2007, 48(3): 495-501. 11. 杨丽.正交设计对“加味通腑汤”进行组方优化的实验 (活血化瘀组)[D]. 沈阳:辽宁中医药大学, 2012. 12. Arie Levine, Gabrie Kenet, Rafael Bruck, et al. Effect of heparin on tissue binding activity of fibroblast growth factor and heparin-binding epidermal growth factor in experimental colitis in rats[J]. Pediatric research, 2002, 51(5): 635-640. 13. Li Xiao, Yang Xiao-lai, Cai Yong-qing, et al. Molecules. Proanthocyanidins from grape seeds modulate the NF-κB signal transduction pathways in rats with TNBS-induced ulcerative colitis[J]. Int Immunopharmacol, 2011, 16(8):6721-6731. 14. He Xiang-yi, Zheng Zhong, Yang Xiang-yi, et al. Tetramethylpyrazine attenuates PPAR-γ antagonist-deteriorated oxazolone-induced colitis in mice[J]. Mol Med Rep. 2012 Mar;5(3):645-50. 15. Marta Sobczak, Pitor K Zakrzewski, Adam I Cygankiewicz, et al. Anti-inflammatory action of a novel orally available peptide 317 in mouse models of inflammatory bowel diseases[J].Pharmacol Rep, 2014, 66(5):741-750. 16. Vijay Morampudi, Ganive Bhinder, Wu Xiu-juan, et al. DNBS/TNBS colitis models: providing insights into inflammatory bowel disease and effects of dietary fat[J]. J Vis Exp. 2014 Feb 27;(84):e51297. 17. 姚惠芬, 陈务华, 周毅. 溃疡性结肠炎动物模型研究概况[J]. 天津药学, 2006, 18(4): 72-74. 18. 张毅. 加味乌梅丸治疗溃疡性结肠炎免疫机制的实验研究[D].北京:北京中医药大学, 2007. 19. Ebert E C. Tumour necrosis factor-α enhances intraepithelial lymphocyte proliferation and migration[J].Gut, 1998, 42(5): 650-655. 20. 王雪茜.不同给药途径对溃疡性结肠炎免疫及修复机制影响的比较性研究[D].北京:北京中医药大学, 2005. 21. 董庆志, 张书信. 愈溃消息方联合美沙拉嗪治疗溃疡性结肠炎相关性息肉的临床和实验研究[D]. 北京:北京中医药大学, 2014. 22. 庞艳华, 郑长青. Thl/Th2细胞亚群与炎症性肠病的关系[J].世界华人消化杂志, 2004, 12(8): 1922-1924. 23. Guillaume Bouguen, Jean-Baptiste Chevaux, Laurent Peyrin-Biroulet. Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases [J]. World J Gastroenterol, 2011, 17(5): 547-556. 24. Abraham C, Cho J H. Inflammatory bowel disease [J]. N Engl J Med, 2009, 361(21):2066-2078. 25. Franco Scaldaferri, Claudio Fiocchi. Inflammatory bowel disease: progress and current concepts of etiopathogenesis [J]. J Dig Dis, 2007, 8(4): 171-178. |
[1] | ZHANG Jian-mei, ZHANG Dan-shen.Advances in Research on Treatment of Ulcerative Colitis with Chinese and Western Medicine#br#[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(5): 43-47. |
[2] | GUO Zi-xia, AN Zi-xuan, ZHANG Jian-mei, ZHANG Dan-shen.Research Progress of Signal Pathways in Drug Treatment of Ulcerative Colitis[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(4): 41-50. |
[3] | LIU Shan, LI Wei.Research Progress on Pharmacological Effects of L-theanine[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(2): 24-32. |
[4] | ZHENG Bei-bei, FENG Shuo, GUO Meng-yuan, FENG Pu, CEN Juan, ZHANG Feng.The Role of Reactive Oxygen Species in Promoting Angiogenesis and Its Important Role in Intracerebral Diseases[J]. ACTA NEUROPHARMACOLOGICA, 2020, 10(1): 24-28. |
[5] | ZHANG Qun-feng,HE Huan-ying,LIAO Yun-hao,WANG Guo-qing.The Effects of Maternal Chlorpyrifos Exposure on the Expression of COX2,CREB and BDNF in Hippocampus of Offspring Mice[J]. Acta Neuropharmacologica, 2019, 9(6): 1-5. |
[6] | QI Gi,WU Hong-li,QI Quan, et al.Correlation between Progesterone Supplementation in the Early Pregnancy and Incidence of Gestational Diabetes Mellitus[J]. Acta Neuropharmacologica, 2019, 9(6): 6-10. |
[7] | YANG Jing,YUAN Wen-ying.Toxoplasma Infection on Nerve Tissue Damage and Its Mechanism through the Blood-Brain Barrier[J]. Acta Neuropharmacologica, 2019, 9(5): 40-43. |
[8] | ZHANG Shuai,AI Jing.Glutamate Dysfunction and Alzheimer’s Disease[J]. Acta Neuropharmacologica, 2018, 8(6): 9-20. |
[9] | ZHU Chao,DU Ning-ning,ZHOU Yan-meng,WANG Hao,HOU Xue-qin,ZHANG Fang-fang,TAN Rui,GAO.Increased Blood Pressure Variability Impairs Memory in Rats[J]. Acta Neuropharmacologica, 2018, 8(5): 79-80. |
[10] | ZHANG Fang-fang1,ZHOU Yan-memg1,WANG Hao1,GAO Shan1,WANG Lei1,TAN Rui1,DU Xian1,ZHAO Xiao-min1,ZHANG Han-ting1,2 *.PDE4 Inhibitor Ameliorates Neuropathic Pain by Upregulating Spinal Connexin 43 Expression[J]. Acta Neuropharmacologica, 2018, 8(4): 8-9. |
[11] | WANG Hao1, ZHANG Fang-fang1, FU Hua-rong1, ZHOU Yan-meng1, LIU Xin1, HOU Xue-qin 1, HU Wei2, Rolf Hansen2, XU Ying3, James O’Donnell3, ZHANG Han-ting1,2.Targeting PDE4 for Alzheimer’s Disease and Alcoholism: An implication in Alcohol-Related Dementia?[J]. Acta Neuropharmacologica, 2018, 8(4): 39-41. |
[12] | ZAN Gui-ying,SUN Xiang,LI Qing-lin,LIU Jing-gen.Research Progress of the Role and Underlying Mechanism of Dynorphin/κ Opioid Receptor in the Development of Depression[J]. Acta Neuropharmacologica, 2018, 8(1): 54-64. |
[13] | HAO Jun-rong,ZHANG Dan-shen,GONG Yue-wen.Autophagy and Bone Mmorphogenetic Proteins in Diseases and Their Relationship[J]. Acta Neuropharmacologica, 2017, 7(6): 41-49. |
[14] | CAI Hong-ling,CHENG Jian-jun,PAN Qi,MIAO Hong,SHANG Ya-zhen.The Effect of Scutellaria Barbata Flavonoid Against N2a Cells Injury Induced by Aβ25-35[J]. Acta Neuropharmacologica, 2017, 7(5): 9-. |
[15] | ZHNAG Jia-lin,LI Yuan-yuan,YANG Wen-liang,LIU Fu-jia,TIAN Zi-xia,XIE Xin-mei,PANG Xiao-bin.Astragaloside IV Protect PC12 Cells under Stress Induced by Oxygen-Glucose Deprivation Involving PI3K/Akt/Bcl-2 Pathway[J]. Acta Neuropharmacologica, 2017, 7(5): 1-9. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||